Clinical Trials Directory

Trials / Completed

CompletedNCT01908868

A Trial of EBUS-TBNA Versus Conventional TBNA in Diagnosis of Sarcoidosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh · Academic / Other
Sex
All
Age
15 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that conventional or EBUS-TBNA will have equal efficiency in diagnosing sarcoidosis when performed in conjunction with endobronchial and transbronchial lung biopsy.

Detailed description

Diagnostic procedures like transbronchial lung biopsy (TBLB), transbronchial needle aspiration (TBNA) and endobronchial biopsy (EBB) are routinely used to obtain pathological confirmation of pulmonary sarcoidosis. Real-time convex probe endobronchial ultrasound-guided TBNA (EBUS-TBNA) has shown immense potential, however it is costly, labor intensive and still has limited availability, especially in low and middle income countries. In the past, TBLB has been the bronchoscopic procedure of choice for diagnosis of sarcoidosis however currently its role is being debated with the advent of EBUS. We have observed that EBUS even though has high yield yet the optimal diagnosis is obtained only when combined with EBB and TBLB. The investigators hypothesize that conventional or EBUS-TBNA will have equal efficiency in diagnosing sarcoidosis when performed in conjunction with endobronchial and transbronchial lung biopsy. The study compares the diagnostic yield of EBUS-TBNA (plus EBB and TBLB) vs. conventional TBNA (plus EBB and TBLB) for diagnosis of sarcoidosis.

Conditions

Interventions

TypeNameDescription
OTHEREBUS-TBNAMediastinal and hilar lymph node aspiration using endobronchial ultrasound
OTHERConventional TBNAMediastinal and hilar lymph node aspiration using blind transbronchial needle aspiration
OTHEREndobronchial and transbronchial biopsyEndobronchial and transbronchial lung biopsy using flexible bronchoscopy

Timeline

Start date
2011-11-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2013-07-26
Last updated
2014-12-30

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01908868. Inclusion in this directory is not an endorsement.